Cellectis (CLLS) Net Equity Issued and Repurchased (2022)
Cellectis' (CLLS) quarterly Net Equity Issued and Repurchased came in at $11.2 million in Q1 2022.
Cellectis (CLLS) Net Equity Issued and Repurchased (2022) Analysis & Trends
Cellectis' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $11.2 million for Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | 141.90 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 11.21 Mn |
| Mar 31, 2022 | 11.21 Mn |